Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome-Reference-Cited by-同舟云学术

Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome

Published:2018-03-07 Issue:8 Volume:53 Page:1072-1075
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Raboud Maude,Beauverd Yan,Simonetta Federico,Dantin Carole,Pradier Amandine,Tsopra Olga,Koutsi Aikaterini,Mamez Anne-Claire,Stephan Caroline,Rodriguez Morales Juan Felipe,Polchlopek-Blasiak Karolina,Tirefort Yordanka,Masouridi-Levrat Stavroula,Chalandon Yves

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0136-2.pdf

Reference10 articles.

1. Bartenstein M, Deeg HJ. Hematopoietic stem cell transplantation for MDS. Hematol Oncol Clin North Am. 2010;24(2):407–22.

2. Porta MGD, Alessandrino EP, Bacigalupo A, Lint MT, van, Malcovati L, Pascutto C, et al. Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. Blood. 2014;123(15):2333–42.

3. Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood. 2004;104(2):579–85.

4. Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005;36(9):757–69.

5. Chakrabarti S, MacDonald D, Hale G, Holder K, Turner V, Czarnecka H, et al. T-cell depletion with Campath-1H “in the bag” for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival. Br J Haematol. 2003;121(1):109–18.